Design, synthesis, in vitro evaluation and molecular docking study of N′-Arylidene imidazo [1,2-a] pyridine-2-carbohydrazide derivatives as novel Tyrosinase inhibitors

被引:14
|
作者
Damghani, Tahereh [1 ,2 ]
Hadaegh, Saba [1 ,2 ]
Khoshneviszadeh, Mahsima [1 ]
Pirhadi, Somayeh [1 ]
Sabet, Razieh [2 ]
Khoshneviszadeh, Mehdi [1 ,2 ]
Edraki, Najmeh [1 ]
机构
[1] Shiraz Univ Med Sci, Med & Nat Prod Chem Res Ctr, Shiraz, Iran
[2] Shiraz Univ Med Sci, Sch Pharm, Dept Med Chem, Shiraz, Iran
关键词
Tyrosinase inhibitor; Imidazo [1,2-a]pyridine; Docking; Kojic acid; KINETIC MECHANISM; AGENTS; POTENT;
D O I
10.1016/j.molstruc.2020.128876
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
A novel series of imidazo[1,2-r]pyridine 2-carbohudrazide derivatives bearing different arylidene pendantrs were designed, synthesized and evaluated for their inhibitory activity against mushroom Tyrosinase. It was found that compounds bearing 3-nitro (6j) and 4-hydroxy (6g) moieties on the arylidene pendant exhibited the best Tyrosinase inhibitory activity with IC50 values of 7.19 and 8.11 mu M, respectively. These results were comparable to that of kojic acid as the reference drug (IC50 = 9.64+0.5 mu M). Additionally, molecular docking analysis was performed to study the interactions and binding modes of compounds 6j, 6h and 6g which are showing the potential of two critical pi-pi interactions with His263 and Phe264 in the active site of Tyrosinase. The results indicated that 6j and 6g could be introduced as potent Tyrosinase inhibitors that might serve as promising candidates in medicine, cosmetics or food industry. (C) 2020 Elsevier B.V. All rights reserved.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Synthesis and antimicrobial screening of novel series of imidazo-[1,2-a]pyridine derivatives
    N. C. Desai
    M. R. Pandya
    K. M. Rajpara
    V. V. Joshi
    H. V. Vaghani
    H. M. Satodiya
    Medicinal Chemistry Research, 2012, 21 : 4437 - 4446
  • [32] Structure-based design, synthesis, and evaluation of imidazo[1,2-b]pyridazine and imidazo[1,2-a]pyridine derivatives as novel dual c-Met and VEGFR2 kinase inhibitors
    Matsumoto, Shigemitsu
    Miyamoto, Naoki
    Hirayama, Takaharu
    Oki, Hideyuki
    Okada, Kengo
    Tawada, Michiko
    Iwata, Hidehisa
    Nakamura, Kazuhide
    Yamasaki, Seiji
    Miki, Hiroshi
    Hori, Akira
    Imamura, Shinichi
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (24) : 7686 - 7698
  • [33] Novel Benzo[4,5]imidazo[1,2-a]pyrimidine derivatives as selective Cyclooxygenase-2 Inhibitors: Design, synthesis, docking studies, and biological evaluation
    Maryam Bayanati
    Mona Khoramjouy
    Mehrdad Faizi
    Mahsa Azami Movahed
    Mohammad Mahboubi-Rabbani
    Afshin Zarghi
    Medicinal Chemistry Research, 2023, 32 : 495 - 505
  • [34] Novel Benzo[4,5]imidazo[1,2-a]pyrimidine derivatives as selective Cyclooxygenase-2 Inhibitors: Design, synthesis, docking studies, and biological evaluation
    Bayanati, Maryam
    Khoramjouy, Mona
    Faizi, Mehrdad
    Movahed, Mahsa Azami
    Mahboubi-Rabbani, Mohammad
    Zarghi, Afshin
    MEDICINAL CHEMISTRY RESEARCH, 2023, 32 (03) : 495 - 505
  • [35] N-Substituted Arylidene-3-(Methylsulfonyl)-2-Oxoimidazolidine-1-Carbohydrazide as Cholinesterase Inhibitors: Design, Synthesis, and Molecular Docking Study
    Tok, Fatih
    Saglik, Begum Nurpelin
    Ozkay, Yusuf
    Kaplancikli, Zafer Asim
    Kocyigit-Kaymakcioglu, Bedia
    CHEMISTRY & BIODIVERSITY, 2022, 19 (08)
  • [36] Design, synthesis and promising anti-tumor efficacy of novel imidazo [1,2-a]pyridine derivatives as potent autotaxin allosteric inhibitors
    Lei, Hongrui
    Wang, Xinyu
    Zhao, Guolong
    Li, Tong
    Cui, Youbao
    Wu, Huinan
    Yang, Jing
    Jiang, Nan
    Zhai, Xin
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 236
  • [37] Synthesis and biological evaluation of imidazo[1,2-a]pyridine derivatives as novel PI3 kinase p110α inhibitors
    Hayakawa, Masahiko
    Kaizawa, Hiroyuki
    Kawaguchi, Ken-ichi
    Ishikawa, Noriko
    Koizumi, Tomonobu
    Ohishi, Takahide
    Yamano, Mayumi
    Okada, Minoru
    Ohta, Mitsuaki
    Tsukamoto, Shin-ichi
    Raynaud, Florence I.
    Waterfield, Michael D.
    Parker, Peter
    Workman, Paul
    BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (01) : 403 - 412
  • [38] A novel series of imidazo[1,2-a]pyridine derivatives as HIF-1α prolyl hydroxylase inhibitors
    Warshakoon, Namal C.
    Wu, Shengde
    Boyer, Angelique
    Kawamoto, Richard
    Sheville, Justin
    Renock, Sean
    Xu, Kevin
    Pokross, Matthew
    Evdokimov, Artem G.
    Walter, Richard
    Mekel, Marlene
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (21) : 5598 - 5601
  • [39] Design, Synthesis, Anti-Cancer Activity, andin silicoStudies of Novel Imidazo[1,2-a]pyridine Derivatives
    Endoori, S.
    Gulipalli, K. C.
    Bodige, S.
    Chandra, J. N. Narendra Sharath
    Seelam, N.
    RUSSIAN JOURNAL OF GENERAL CHEMISTRY, 2020, 90 (09) : 1727 - 1736
  • [40] Design, Synthesis, Anti-Cancer Activity, and in silico Studies of Novel Imidazo[1,2-a]pyridine Derivatives
    S. Endoori
    K. C. Gulipalli
    S. Bodige
    J. N. Narendra Sharath Chandra
    N. Seelam
    Russian Journal of General Chemistry, 2020, 90 : 1727 - 1736